1. Rerup, C.C., 1970, Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22:485–518.
2. Gaulton, G.N., Schwartz, J.L., and Eardley, D.D., 1985, Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice. Diabetologia 28:769–775.
3. Zafirova, M., Jablenska, R., Popov, A., Goranova, I., Vassileva, E., Duhault, J., Marquie, G., and Petkov, P., 1991, Morphological characteristics of the endocrine pancreas in alloxandiabetes after cyclosporin A administration. Cellular and Molecular Biology 37:585–596.
4. Wright, C. E., Tallen, H.H., Lin, Y. Y., Gaull, G.E., 1986, Taurine Biological update. Ann Rev. Biochem 55:427–453.
5. Briel, G., Gylfe, E., Hellman and Neuhoff, V., 1972, Microdetermination of free amino acids in pancreatic islets isolated from obese-hyperglycemic mice. Acta. Physiol. Scand. 84:247–253.